ArticleOncotarget2016

Arctigenin functions as a selective agonist of estrogen receptor β to restrict mTORC1 activation and consequent Th17 differentiation.

Xin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.